companiesSEC EDGAR
MoonLake Immunotherapeutics

SEC EDGAR published this disclosure on 2026-08-10. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001821586-26-000010
cik1821586
company nameMoonLake Immunotherapeutics
form10-Q